Table 1.
Clinical and demographic information of the patients and healthy controls
| Sex | Age | Education | Acute disease symptoms | Neoplasms | MRI | Treatment | Duration of disease when did neuropsychological tests |
|
|---|---|---|---|---|---|---|---|---|
| Patient_1 (HLP) | F | 35 | 12 | seizures | none | abnormal | IVIg, Steroids, AEDs | 1 m, 4 m, 2.5y |
| Patient_2 | M | 49 | 5 | seizures, behavioral and psychological symptoms | none | normal | IVIg, Steroids, AEDs | 1 m, 1.5y |
| Patient_3 | F | 42 | 16 | seizures | none | normal | IVIg, Steroids, AEDs | 5 m, 2y |
| Patient_4 | M | 59 | 3 | seizures, behavioral and psychological symptoms | none | normal | IVIg, Steroids, AEDs | 3y |
| Patient_5 | F | 61 | 4 | seizures, behavioral and psychological symptoms | none | normal | IVIg, AEDs | 1y |
| Control_1 | F | 35 | 7 | |||||
| Control_2 | M | 49 | 9 | |||||
| Control_3 | F | 42 | 5 | |||||
| Control_4 | M | 60 | 8 | |||||
| Control_5 | F | 67 | 15 |
AEDs antiepileptic drugs, IVIg intravenous human immunoglobulin